2.要約中間連結財務諸表及び主な注記

(1)要約中間連結財政状態計算書

 

 

 

(単位:千円)

 

前連結会計年度

(2024年12月31日)

 

当中間連結会計期間

(2025年6月30日)

資産

 

 

 

非流動資産

 

 

 

有形固定資産

5,696,491

 

5,202,097

使用権資産

1,559,345

 

1,527,049

のれん

15,994,981

 

14,666,004

無形資産

11,026,585

 

11,268,661

持分法で会計処理されている投資

386,978

 

360,559

繰延税金資産

2,234,803

 

2,129,756

その他の金融資産

5,764,350

 

5,075,942

その他の非流動資産

56,730

 

69,964

非流動資産合計

42,720,266

 

40,300,037

 

 

 

 

流動資産

 

 

 

棚卸資産

2,529,642

 

3,383,760

営業債権及びその他の債権

6,236,284

 

5,673,462

その他の金融資産

9,291,037

 

7,078,558

その他の流動資産

1,050,642

 

761,439

現金及び現金同等物

10,115,037

 

10,524,916

流動資産合計

29,222,643

 

27,422,138

資産合計

71,942,909

 

67,722,176

 

 

 

 

負債及び資本

 

 

 

非流動負債

 

 

 

借入金

1,200,000

 

1,000,000

リース負債

735,590

 

735,337

繰延税金負債

2,171,430

 

2,047,733

その他の金融負債

15,454,160

 

14,832,646

その他の非流動負債

203,422

 

388,159

非流動負債合計

19,764,605

 

19,003,877

 

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

2,263,911

 

1,950,446

借入金

4,575,000

 

2,400,000

1年内返済予定の長期借入金

400,000

 

400,000

リース負債

295,289

 

326,734

未払法人所得税

2,611,203

 

2,710,737

その他の金融負債

888

 

4,495

その他の流動負債

2,318,111

 

2,612,282

流動負債合計

12,464,403

 

10,404,696

負債合計

32,229,009

 

29,408,573

 

 

 

 

資本

 

 

 

資本金

13,276,700

 

13,463,507

資本剰余金

6,626,254

 

8,874,885

自己株式

15,372

 

15,629

利益剰余金

9,888,797

 

8,973,417

その他の資本の構成要素

6,669,736

 

3,973,112

親会社の所有者に帰属する持分合計

36,446,115

 

35,269,293

非支配持分

3,267,785

 

3,044,309

資本合計

39,713,900

 

38,313,602

資本及び負債の合計

71,942,909

 

67,722,176

 

E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2025-01-012025-06-30Q22025-12-312024-01-012024-06-302024-12-311falsefalsefalse216002023-12-31216002024-12-31216002024-01-012024-06-30216002024-06-30216002025-01-012025-06-30216002025-06-30216002025-08-14216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-12-31jpigp_cor:ShareCapitalIFRSMember216002024-12-31jpigp_cor:CapitalSurplusIFRSMember216002024-12-31jpigp_cor:TreasurySharesIFRSMember216002024-12-31jpigp_cor:RetainedEarningsIFRSMember216002024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002025-01-012025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-01-012025-06-30jpigp_cor:ShareCapitalIFRSMember216002025-01-012025-06-30jpigp_cor:CapitalSurplusIFRSMember216002025-01-012025-06-30jpigp_cor:TreasurySharesIFRSMember216002025-01-012025-06-30jpigp_cor:RetainedEarningsIFRSMember216002025-01-012025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-01-012025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-01-012025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-01-012025-06-30jpigp_cor:NonControllingInterestsIFRSMember216002025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-06-30jpigp_cor:ShareCapitalIFRSMember216002025-06-30jpigp_cor:CapitalSurplusIFRSMember216002025-06-30jpigp_cor:TreasurySharesIFRSMember216002025-06-30jpigp_cor:RetainedEarningsIFRSMember216002025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpcrp_cor:ReportableSegmentsMember216002024-01-012024-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002025-01-012025-06-30jpcrp_cor:ReportableSegmentsMember216002025-01-012025-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002025-01-012025-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMemberiso4217:JPYxbrli:pureiso4217:JPYxbrli:shares